Sign In
Buy ADVM
$4.36
+0 (+0%)
At Close: Mar 06, 2026
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Shares Purchased by United Capital Financial Advisers LLC
07:38am, Thursday, 25'th Jun 2020
United Capital Financial Advisers LLC grew its stake in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 35.4% during the 1st quarter, HoldingsChannel.com reports. The fund owned 1,200 shares
Adverum Biotechnologies Announces Appointment of Heikki Jouttijärvi as Vice President of Manufacturing
12:00am, Thursday, 25'th Jun 2020
-- Plans underway to begin expansion of manufacturing capabilities -- REDWOOD CITY, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies,...
Health Care Down, But Not By Much, Amid Defensive Bias -- Health Care Roundup
09:02pm, Wednesday, 24'th Jun 2020Regeneron accused of using charity to pay kickbacks to Medicare patients
05:23pm, Wednesday, 24'th Jun 2020
Senior executives at Regeneron "allegedly took extensive measures to cover up the scheme," said U.S. Attorney Andrew Lelling.
Xconomy: AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis
10:55am, Wednesday, 24'th Jun 2020
The body’s natural process for healing wounds has led AsclepiX Therapeutics to a novel approach to treating diseases of the eye. The startup is now
Editas Medicine Falling 6% In Pre-Market On Offer Pricing
09:12am, Wednesday, 24'th Jun 2020
Shares in Editas Medicine (EDIT) are falling 6% in Wednesday’s pre-market trading after the company announced a price of $31.25 per share for its
Adverum Biotechnologies (NASDAQ:ADVM) Hits New 1-Year High at $25.50
06:15am, Wednesday, 24'th Jun 2020
Adverum Biotechnologies Inc (NASDAQ:ADVM) reached a new 52-week high on Monday . The company traded as high as $25.50 and last traded at $25.50, with a volume of 61112 shares. The stock had previously
